Outcomes from intracerebral hemorrhage among patients pre-treated with statins

Arquivos de Neuro-Psiquiatria

Flávio Ramalho Romero²  Eduardo De Freitas Bertolini¹  Vanessa Nogueira Veloso¹  Leandro Venturini¹  Eberval G. Figueiredo¹ 

[1] ,Hospital Ipiranga

关键词: cerebral hemorrhage;    hydroxymethylglutaryl-CoA reductase inhibitors;    hemorragia cerebral;    inibidores de hidroximetilglutaril-CoA redutases;   

DOI  :  10.1590/S0004-282X2011000400008

来源: SciELO

【 摘 要 】

OBJECTIVE: 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, have been associated with improved clinical outcomes after ischemic stroke and subarachnoid hemorrhage, but with an increased risk of incidental spontaneous intracerebral hemorrhage (ICH). We investigated whether the statin use before ICH, was associated with functional independence, 90 days after treatment. METHOD: We analyzed 124 consecutive ICH patients with 90-day outcome data who were enrolled in a prospective cohort study between 2006 and 2009. Eighty-three patients were included in this study. Among ICH survivors, univariate Cox regression models and Kaplan-Meier plots were used to determine subject characteristics that were associated with an increased risk of recurrence. Statin usage was determined through interviewing the patient at the time of ICH and confirmed by reviewing their medical records. Independent status was defined as Glasgow Outcome Scale grades 4 or 5. RESULTS: Statins were used by 20 out of 83 patients (24%) before ICH onset. There was no effect from pre-ICH statin use on functional independence rates (28% versus 29%, P=0.84) or mortality (46% versus 45%, P=0.93). CONCLUSION: Pre-ICH statin use is not associated with changes to ICH functional outcome or mortality.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License